Quarterly Result22 May 2026, 08:51 pm
Bacil Pharma Audited Results for March 31, 2026
AI Summary
Bacil Pharma Ltd's board meeting on May 22, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The meeting, which commenced at 05:00 P.M. and concluded at 08:00 P.M., also included a review of other business activities. The balance sheet shows total assets of ₹2739.26 Lacs as of March 31, 2026, compared to ₹2560.02 Lacs in the previous year. Equity Share capital remained at ₹1397.02 Lacs.
Key Highlights
- Audited financial results for the quarter and year ended March 31, 2026, approved.
- Total assets increased to ₹2739.26 Lacs as of March 31, 2026.
- Equity Share capital steady at ₹1397.02 Lacs.
- The Board meeting was held on May 22, 2026.
Price Impact
More from BACPHAR